Skip to content

ICU Medical ICUI Business Segments

FY'25FY'24FY'23FY'22
Revenue, Remaining Performance Obligation, Amount by Product
Equipment revenue$77.28M+6.0%$72.92M+8.4%$67.27M-12.1%$76.5M+284%
Government Grant Revenue$24.23M-25.4%$32.49M-30.1%$46.47M-12.2%$52.9M
Other deferred revenue$4.05M+162%$1.55M-85.4%$10.59M-60.2%$26.6M
Software revenue$27.56M-32.9%$41.11M+18.6%$34.65M+8.4%$31.98M+433%
Revenue by Product
Infusion Consumables$1.11B+6.8%$1.04B+7.2%$969.13M-0.6%$974.99M+75.6%
Infusion Systems$684.21M+4.9%$652.41M+3.7%$629.04M+1.9%$617.44M+75.2%
Vital Care$437.92M-36.6%$690.77M+4.5%$660.95M-3.9%$687.57M+68.2%
Percentage of revenue by Product
Infusion Consumables50%+6.0pp44%+1.0pp43%0.0pp43%+1.0pp
Infusion Systems31%+4.0pp27%-1.0pp28%+1.0pp27%0.0pp
Vital Care19%-10.0pp29%0.0pp29%-1.0pp30%-1.0pp
Revenue by Geography
APAC$232.9M0.0%$232.82M-3.7%$241.7M-6.0%$257.21M+200%
UNITED STATES$1.36B-11.5%$1.53B+6.4%$1.44B-1.4%$1.46B+55.0%
Percent of total revenue by Geography
International Sales39%+3.0pp36%0.0pp36%0.0pp36%+8.0pp
UNITED STATES61%-3.0pp64%0.0pp64%0.0pp64%-8.0pp
Total property and equipment, cost by Geography
Asia Pacific$114.16M
CANADA$7.3M
COSTA RICA$650.62M
CZECHIA$54.42M
Europe$45.4M
Foreign$1.83B
ITALY$136.1M
MEXICO$480.13M
Other LATAM$262.1M
SPAIN$79.61M
UNITED STATES$2.49B

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does ICU Medical break its business down?
ICU Medical (ICUI) reports revenue, remaining performance obligation, amount by product across 4 parts — Equipment revenue, Government Grant Revenue, Other deferred revenue and Software revenue. Each is extracted from the segment footnotes and tracked over time.
Where does ICU Medical's segment data come from?
Segment breakdowns are pulled from the segment footnotes in ICU Medical's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.